HEADER IMMUNE SYSTEM 27-JAN-09 3G04 TITLE CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- TITLE 2 STIMULATING AUTOANTIBODY CAVEAT 3G04 NAG A 213 HAS WRONG CHIRALITY AT ATOM C1 NAG C 1 HAS WRONG CAVEAT 2 3G04 CHIRALITY AT ATOM C1 NAG C 2 HAS WRONG CHIRALITY AT ATOM C1 CAVEAT 3 3G04 NAG C 3 HAS WRONG CHIRALITY AT ATOM C1 NAG C 5 HAS WRONG CAVEAT 4 3G04 CHIRALITY AT ATOM C1 NAG C 6 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMAN THYROID STIMULATING AUTOANTIBODY M22 LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FAB FRAGMENT LIGHT CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HUMAN THYROID STIMULATING AUTOANTIBODY M22 HEAVY CHAIN; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: FAB FRAGMENT HEAVY CHAIN; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: THYROTROPIN RECEPTOR; COMPND 13 CHAIN: C; COMPND 14 FRAGMENT: LEUCINE RICH REPEAT DOMAIN (SEGMENT 22-260); COMPND 15 SYNONYM: THYROID-STIMULATING HORMONE RECEPTOR, TSH-R; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: MOUSE-HUMAN HETEROHYBRIDOMA CELL LINE; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 37965; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: MOUSE-HUMAN HETEROHYBRIDOMA CELL LINE; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 37965; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 GENE: TSHR; SOURCE 18 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 20 EXPRESSION_SYSTEM_STRAIN: HIGH FIVE; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TSH RECEPTOR, GPCR, THYROID, GRAVES' DISEASE, AUTOIMMUNITY, RECEPTOR- KEYWDS 2 AUTOANTIBODY COMPLEX, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.SANDERS,D.Y.CHIRGADZE,P.SANDERS,S.BAKER,A.SULLIVAN,A.BHARDWAJA, AUTHOR 2 J.BOLTON,M.REEVE,N.NAKATAKE,M.EVANS,T.RICHARDS,M.POWELL,R.N.MIGUEL, AUTHOR 3 T.L.BLUNDELL,J.FURMANIAK,B.R.SMITH REVDAT 4 01-NOV-23 3G04 1 HETSYN REVDAT 3 29-JUL-20 3G04 1 CAVEAT COMPND REMARK HETNAM REVDAT 3 2 1 LINK SITE REVDAT 2 13-JUL-11 3G04 1 VERSN REVDAT 1 04-AUG-09 3G04 0 JRNL AUTH J.SANDERS,D.Y.CHIRGADZE,P.SANDERS,S.BAKER,A.SULLIVAN, JRNL AUTH 2 A.BHARDWAJA,J.BOLTON,M.REEVE,N.NAKATAKE,M.EVANS,T.RICHARDS, JRNL AUTH 3 M.POWELL,R.N.MIGUEL,T.L.BLUNDELL,J.FURMANIAK,B.R.SMITH JRNL TITL CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A JRNL TITL 2 THYROID-STIMULATING AUTOANTIBODY JRNL REF THYROID V. 17 395 2007 JRNL REFN ISSN 1050-7256 JRNL PMID 17542669 JRNL DOI 10.1089/THY.2007.0034 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.SANDERS,M.EVANS,L.D.K.E.PREMAWARDHANA,H.DEPRAETERE, REMARK 1 AUTH 2 J.JEFFREYS,T.RICHARDS,J.FURMANIAK,B.R.SMITH REMARK 1 TITL HUMAN MONOCLONAL THYROID STIMULATING AUTOANTIBODY REMARK 1 REF LANCET V. 362 126 2003 REMARK 1 REFN ISSN 0140-6736 REMARK 1 PMID 12867115 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.SANDERS,J.JEFFREYS,H.DEPRAETERE,M.EVANS,T.RICHARDS, REMARK 1 AUTH 2 A.KIDDIE,K.BRERETON,L.D.K.E.PREMAWARDHANA,D.Y.CHIRGADZE, REMARK 1 AUTH 3 R.N.MIGUEL,T.L.BLUNDELL,J.FURMANIAK,B.R.SMITH REMARK 1 TITL CHARACTERISTICS OF A HUMAN MONOCLONAL AUTOANTIBODY TO THE REMARK 1 TITL 2 THYROTROPIN RECEPTOR: SEQUENCE STRUCTURE AND FUNCTION REMARK 1 REF THYROID V. 14 560 2004 REMARK 1 REFN ISSN 1050-7256 REMARK 1 PMID 15320966 REMARK 1 DOI 10.1089/1050725041692918 REMARK 1 REFERENCE 3 REMARK 1 AUTH R.N.MIGUEL,J.SANDERS,J.JEFFREYS,H.DEPRAETERE,M.EVANS, REMARK 1 AUTH 2 T.RICHARDS,T.L.BLUNDELL,B.REES SMITH,J.FURMANIAK REMARK 1 TITL ANALYSIS OF THE THYROTROPIN RECEPTOR-THYROTROPIN INTERACTION REMARK 1 TITL 2 BY COMPARATIVE MODELING REMARK 1 REF THYROID V. 14 991 2004 REMARK 1 REFN ISSN 1050-7256 REMARK 1 PMID 15650352 REMARK 1 DOI 10.1089/THY.2004.14.991 REMARK 1 REFERENCE 4 REMARK 1 AUTH R.N.MIGUEL,J.SANDERS,T.L.BLUNDELL,B.R.SMITH,J.FURMANIAK REMARK 1 TITL COMPARATIVE MODELLING OF THE THYROTROPIN RECEPTOR REMARK 1 REF THYROID V. 15 746 2005 REMARK 1 REFN ISSN 1050-7256 REMARK 1 REFERENCE 5 REMARK 1 AUTH J.SANDERS,J.BOLTON,P.SANDERS,J.JEFFREYS,N.NAKATAKE, REMARK 1 AUTH 2 T.RICHARDS,M.EVANS,A.KIDDIE,S.SUMMERHAYES,E.ROBERTS, REMARK 1 AUTH 3 R.N.MIGUEL,J.FURMANIAK,B.R.SMITH REMARK 1 TITL EFFECTS OF TSH RECEPTOR MUTATIONS ON BINDING AND BIOLOGICAL REMARK 1 TITL 2 ACTIVITY OF MONOCLONAL ANTIBODIES AND TSH REMARK 1 REF THYROID V. 16 1195 2006 REMARK 1 REFN ISSN 1050-7256 REMARK 1 PMID 17199429 REMARK 1 DOI 10.1089/THY.2006.16.1195 REMARK 1 REFERENCE 6 REMARK 1 AUTH J.SANDERS,R.N.MIGUEL,J.BOLTON,A.BHARDWAJA,P.SANDERS, REMARK 1 AUTH 2 N.NAKATAKE,M.EVANS,J.FURMANIAK,B.R.SMITH REMARK 1 TITL MOLECULAR INTERACTIONS BETWEEN THE TSH RECEPTOR AND A REMARK 1 TITL 2 THYROID-STIMULATING MONOCLONAL AUTOANTIBODY REMARK 1 REF THYROID V. 17 699 2007 REMARK 1 REFN ISSN 1050-7256 REMARK 1 PMID 17725428 REMARK 1 DOI 10.1089/THY.2007.0041 REMARK 1 REFERENCE 7 REMARK 1 AUTH R.N.MIGUEL,J.SANDERS,D.Y.CHIRGADZE,T.L.BLUNDELL,J.FURMANIAK, REMARK 1 AUTH 2 B.REES SMITH REMARK 1 TITL FSH AND TSH BINDING TO THEIR RESPECTIVE RECEPTORS: REMARK 1 TITL 2 SIMILARITIES, DIFFERENCES AND IMPLICATION FOR GLYCOPROTEIN REMARK 1 TITL 3 HORMONE SPECIFICITY REMARK 1 REF J.MOL.ENDOCRINOL. V. 41 145 2008 REMARK 1 REFN ISSN 0952-5041 REMARK 1 PMID 18606720 REMARK 1 DOI 10.1677/JME-08-0040 REMARK 1 REFERENCE 8 REMARK 1 AUTH R.N.MIGUEL,J.SANDERS,D.Y.CHIRGADZE,J.FURMANIAK,B.R.SMITH REMARK 1 TITL THYROID STIMULATING AUTOANTIBODY M22 MIMICS TSH IN ITS REMARK 1 TITL 2 BINDING TO THE TSH RECEPTOR: A COMPARATIVE STRUCTURAL STUDY REMARK 1 TITL 3 OF PROTEIN-PROTEIN INTERACTIONS REMARK 1 REF TO BE PUBLISHED 2009 REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 24426 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1301 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.61 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1803 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.99 REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE SET COUNT : 95 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5036 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 89 REMARK 3 SOLVENT ATOMS : 289 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 47.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.16000 REMARK 3 B22 (A**2) : -0.19000 REMARK 3 B33 (A**2) : 0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.665 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.303 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.208 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 17.888 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.904 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5255 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7173 ; 1.236 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 651 ; 6.528 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 202 ;39.599 ;24.604 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 834 ;16.207 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;18.934 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 831 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3901 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2170 ; 0.201 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3515 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 322 ; 0.146 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 3 ; 0.177 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 51 ; 0.250 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 16 ; 0.164 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): 1 ; 0.046 ; 0.200 REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3363 ; 1.775 ; 5.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5320 ; 2.673 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2175 ; 2.261 ; 5.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1853 ; 3.392 ; 7.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 30 C 257 REMARK 3 ORIGIN FOR THE GROUP (A): 6.8220 74.0860 16.8290 REMARK 3 T TENSOR REMARK 3 T11: -0.0992 T22: -0.0050 REMARK 3 T33: -0.0796 T12: -0.0102 REMARK 3 T13: 0.0096 T23: 0.0087 REMARK 3 L TENSOR REMARK 3 L11: 0.1583 L22: 1.7188 REMARK 3 L33: 1.4269 L12: -0.2031 REMARK 3 L13: 0.0119 L23: 0.8203 REMARK 3 S TENSOR REMARK 3 S11: -0.0324 S12: 0.0579 S13: 0.0065 REMARK 3 S21: -0.0352 S22: -0.0012 S23: -0.0419 REMARK 3 S31: -0.0790 S32: -0.0457 S33: 0.0336 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 114 REMARK 3 ORIGIN FOR THE GROUP (A): -5.7050 60.6090 38.7090 REMARK 3 T TENSOR REMARK 3 T11: -0.0899 T22: -0.0020 REMARK 3 T33: -0.0185 T12: -0.0633 REMARK 3 T13: 0.0330 T23: -0.0539 REMARK 3 L TENSOR REMARK 3 L11: 0.6876 L22: 0.2971 REMARK 3 L33: 3.0367 L12: 0.2497 REMARK 3 L13: -0.3280 L23: -0.2216 REMARK 3 S TENSOR REMARK 3 S11: 0.0225 S12: 0.0778 S13: -0.0143 REMARK 3 S21: 0.0199 S22: -0.0828 S23: -0.0021 REMARK 3 S31: 0.2942 S32: -0.2416 S33: 0.0603 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 115 B 213 REMARK 3 ORIGIN FOR THE GROUP (A): -16.4510 62.8160 73.8890 REMARK 3 T TENSOR REMARK 3 T11: -0.1106 T22: 0.0031 REMARK 3 T33: 0.0174 T12: 0.0620 REMARK 3 T13: -0.0154 T23: -0.0434 REMARK 3 L TENSOR REMARK 3 L11: 3.3868 L22: 3.6396 REMARK 3 L33: 4.7819 L12: 0.8695 REMARK 3 L13: -1.4842 L23: 1.2853 REMARK 3 S TENSOR REMARK 3 S11: -0.1155 S12: -0.2518 S13: 0.4632 REMARK 3 S21: 0.1353 S22: -0.0225 S23: 0.2909 REMARK 3 S31: -0.3013 S32: -0.3929 S33: 0.1380 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 108 REMARK 3 ORIGIN FOR THE GROUP (A): 12.2550 71.2810 45.0010 REMARK 3 T TENSOR REMARK 3 T11: -0.1118 T22: -0.0111 REMARK 3 T33: -0.0037 T12: 0.0125 REMARK 3 T13: 0.0205 T23: 0.0152 REMARK 3 L TENSOR REMARK 3 L11: 0.3322 L22: 1.1452 REMARK 3 L33: 1.9606 L12: 0.1726 REMARK 3 L13: 0.2609 L23: 0.7424 REMARK 3 S TENSOR REMARK 3 S11: 0.0079 S12: 0.0186 S13: -0.0030 REMARK 3 S21: 0.1340 S22: 0.0002 S23: -0.0481 REMARK 3 S31: 0.0447 S32: 0.0818 S33: -0.0081 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 109 A 208 REMARK 3 ORIGIN FOR THE GROUP (A): -1.0460 58.4750 79.4630 REMARK 3 T TENSOR REMARK 3 T11: -0.0636 T22: -0.0159 REMARK 3 T33: -0.0933 T12: -0.0312 REMARK 3 T13: 0.0285 T23: -0.0223 REMARK 3 L TENSOR REMARK 3 L11: 0.8201 L22: 3.2481 REMARK 3 L33: 1.0542 L12: 1.1967 REMARK 3 L13: -0.0249 L23: -0.4884 REMARK 3 S TENSOR REMARK 3 S11: -0.0206 S12: -0.1103 S13: -0.0105 REMARK 3 S21: 0.0996 S22: 0.0051 S23: 0.0388 REMARK 3 S31: -0.0492 S32: -0.0188 S33: 0.0154 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3G04 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-JAN-09. REMARK 100 THE DEPOSITION ID IS D_1000051254. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-NOV-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25731 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : 0.07100 REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.36100 REMARK 200 R SYM FOR SHELL (I) : 0.36100 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1XWD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% PEG 8000, 0.1M MES, 0.25M ZINC REMARK 280 ACETATE, PH 6.00, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y,-Z REMARK 290 8555 X,-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.94400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 102.90300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 87.89200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 102.90300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.94400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 87.89200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 21.94400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 87.89200 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 102.90300 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 87.89200 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 21.94400 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 102.90300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -79.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 245 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 235 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 294 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 209 REMARK 465 GLU A 210 REMARK 465 CYS A 211 REMARK 465 SER A 212 REMARK 465 SER B 128 REMARK 465 LYS B 129 REMARK 465 SER B 130 REMARK 465 THR B 131 REMARK 465 SER B 132 REMARK 465 GLY B 133 REMARK 465 LYS B 214 REMARK 465 SER B 215 REMARK 465 CYS B 216 REMARK 465 ASP B 217 REMARK 465 LYS B 218 REMARK 465 THR B 219 REMARK 465 SER B 220 REMARK 465 MET C 22 REMARK 465 GLY C 23 REMARK 465 CYS C 24 REMARK 465 SER C 25 REMARK 465 SER C 26 REMARK 465 PRO C 27 REMARK 465 PRO C 28 REMARK 465 CYS C 29 REMARK 465 TRP C 258 REMARK 465 THR C 259 REMARK 465 LEU C 260 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU C 35 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 229 O HOH A 230 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 16 -6.19 67.66 REMARK 500 ASN A 27B -93.82 -113.48 REMARK 500 ASP A 51 -46.06 78.53 REMARK 500 ASP A 52 13.41 -148.27 REMARK 500 LEU A 78 131.07 -39.40 REMARK 500 ASP A 151 -112.21 51.20 REMARK 500 ASP B 144 72.40 49.44 REMARK 500 THR B 191 -48.70 -136.64 REMARK 500 ASP C 36 62.19 -112.67 REMARK 500 ASP C 43 -22.17 70.17 REMARK 500 ILE C 85 64.35 60.52 REMARK 500 LEU C 125 77.40 -119.89 REMARK 500 ASN C 135 71.86 48.62 REMARK 500 GLU C 178 -144.88 -122.05 REMARK 500 LEU C 184 68.64 -118.98 REMARK 500 ASP C 203 -88.70 -99.60 REMARK 500 THR C 236 -163.95 -124.68 REMARK 500 ALA C 254 72.70 -150.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN C 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B 257 O REMARK 620 2 HIS C 63 NE2 81.9 REMARK 620 N 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XWD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN FOLLICLE STIMULATING HORMONE COMPLEXED REMARK 900 WITH ITS RECEPTOR DBREF 3G04 A 1 212 PDB 3G04 3G04 1 212 DBREF 3G04 B 1 220 PDB 3G04 3G04 1 220 DBREF 3G04 C 22 260 UNP P16473 TSHR_HUMAN 22 260 SEQRES 1 A 216 LEU THR VAL LEU THR GLN PRO PRO SER VAL SER GLY ALA SEQRES 2 A 216 PRO ARG GLN ARG VAL THR ILE SER CYS SER GLY ASN SER SEQRES 3 A 216 SER ASN ILE GLY ASN ASN ALA VAL ASN TRP TYR GLN GLN SEQRES 4 A 216 LEU PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR TYR ASP SEQRES 5 A 216 ASP GLN LEU PRO SER GLY VAL SER ASP ARG PHE SER GLY SEQRES 6 A 216 SER ARG SER GLY THR SER ALA SER LEU ALA ILE ARG GLY SEQRES 7 A 216 LEU GLN SER GLU ASP GLU ALA ASP TYR TYR CYS THR SER SEQRES 8 A 216 TRP ASP ASP SER LEU ASP SER GLN LEU PHE GLY GLY GLY SEQRES 9 A 216 THR ARG LEU THR VAL LEU GLY GLN PRO LYS ALA ALA PRO SEQRES 10 A 216 SER VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN SEQRES 11 A 216 ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE SEQRES 12 A 216 TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SER SEQRES 13 A 216 SER PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SER SEQRES 14 A 216 LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SEQRES 15 A 216 SER LEU THR PRO GLU GLN TRP LYS SER HIS LYS SER TYR SEQRES 16 A 216 SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS SEQRES 17 A 216 THR VAL ALA PRO THR GLU CYS SER SEQRES 1 B 228 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 B 228 PRO GLY GLU SER LEU LYS ILE SER CYS ARG GLY SER GLY SEQRES 3 B 228 TYR ARG PHE THR SER TYR TRP ILE ASN TRP VAL ARG GLN SEQRES 4 B 228 LEU PRO GLY LYS GLY LEU GLU TRP MET GLY ARG ILE ASP SEQRES 5 B 228 PRO THR ASP SER TYR THR ASN TYR SER PRO SER PHE LYS SEQRES 6 B 228 GLY HIS VAL THR VAL SER ALA ASP LYS SER ILE ASN THR SEQRES 7 B 228 ALA TYR LEU GLN TRP SER SER LEU LYS ALA SER ASP THR SEQRES 8 B 228 GLY MET TYR TYR CYS ALA ARG LEU GLU PRO GLY TYR SER SEQRES 9 B 228 SER THR TRP SER VAL ASN TRP GLY GLN GLY THR LEU VAL SEQRES 10 B 228 THR VAL SER SER ALA SER THR LYS GLY PRO SER VAL PHE SEQRES 11 B 228 PRO LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR SEQRES 12 B 228 ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU SEQRES 13 B 228 PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER SEQRES 14 B 228 GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY SEQRES 15 B 228 LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SEQRES 16 B 228 SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS SEQRES 17 B 228 LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO SEQRES 18 B 228 LYS SER CYS ASP LYS THR SER SEQRES 1 C 239 MET GLY CYS SER SER PRO PRO CYS GLU CYS HIS GLN GLU SEQRES 2 C 239 GLU ASP PHE ARG VAL THR CYS LYS ASP ILE GLN ARG ILE SEQRES 3 C 239 PRO SER LEU PRO PRO SER THR GLN THR LEU LYS LEU ILE SEQRES 4 C 239 GLU THR HIS LEU ARG THR ILE PRO SER HIS ALA PHE SER SEQRES 5 C 239 ASN LEU PRO ASN ILE SER ARG ILE TYR VAL SER ILE ASP SEQRES 6 C 239 VAL THR LEU GLN GLN LEU GLU SER HIS SER PHE TYR ASN SEQRES 7 C 239 LEU SER LYS VAL THR HIS ILE GLU ILE ARG ASN THR ARG SEQRES 8 C 239 ASN LEU THR TYR ILE ASP PRO ASP ALA LEU LYS GLU LEU SEQRES 9 C 239 PRO LEU LEU LYS PHE LEU GLY ILE PHE ASN THR GLY LEU SEQRES 10 C 239 LYS MET PHE PRO ASP LEU THR LYS VAL TYR SER THR ASP SEQRES 11 C 239 ILE PHE PHE ILE LEU GLU ILE THR ASP ASN PRO TYR MET SEQRES 12 C 239 THR SER ILE PRO VAL ASN ALA PHE GLN GLY LEU CYS ASN SEQRES 13 C 239 GLU THR LEU THR LEU LYS LEU TYR ASN ASN GLY PHE THR SEQRES 14 C 239 SER VAL GLN GLY TYR ALA PHE ASN GLY THR LYS LEU ASP SEQRES 15 C 239 ALA VAL TYR LEU ASN LYS ASN LYS TYR LEU THR VAL ILE SEQRES 16 C 239 ASP LYS ASP ALA PHE GLY GLY VAL TYR SER GLY PRO SER SEQRES 17 C 239 LEU LEU ASP VAL SER GLN THR SER VAL THR ALA LEU PRO SEQRES 18 C 239 SER LYS GLY LEU GLU HIS LEU LYS GLU LEU ILE ALA ARG SEQRES 19 C 239 ASN THR TRP THR LEU MODRES 3G04 ASN A 26 ASN GLYCOSYLATION SITE MODRES 3G04 ASN C 77 ASN GLYCOSYLATION SITE MODRES 3G04 ASN C 99 ASN GLYCOSYLATION SITE MODRES 3G04 ASN C 113 ASN GLYCOSYLATION SITE MODRES 3G04 ASN C 177 ASN GLYCOSYLATION SITE MODRES 3G04 ASN C 198 ASN GLYCOSYLATION SITE HET NAG A 213 14 HET ZN A 304 1 HET ZN A 305 1 HET NAG C 1 14 HET NAG C 2 14 HET NAG C 3 14 HET NAG C 5 14 HET NAG C 6 14 HET ZN C 301 1 HET ZN C 302 1 HET ZN C 303 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG 6(C8 H15 N O6) FORMUL 5 ZN 5(ZN 2+) FORMUL 15 HOH *289(H2 O) HELIX 1 1 GLN A 79 GLU A 83 5 5 HELIX 2 2 SER A 121 ALA A 127 1 7 HELIX 3 3 THR A 181 HIS A 188 1 8 HELIX 4 4 ARG B 28 TYR B 32 5 5 HELIX 5 5 LYS B 73 ILE B 75 5 3 HELIX 6 6 LYS B 83 THR B 87 5 5 HELIX 7 7 SER B 156 ALA B 158 5 3 HELIX 8 8 SER B 187 LEU B 189 5 3 HELIX 9 9 LYS B 201 ASN B 204 5 4 SHEET 1 A 5 SER A 9 GLY A 13 0 SHEET 2 A 5 THR A 102 VAL A 106 1 O THR A 105 N VAL A 11 SHEET 3 A 5 ASP A 85 ASP A 92 -1 N TYR A 86 O THR A 102 SHEET 4 A 5 ASN A 34 GLN A 38 -1 N GLN A 38 O ASP A 85 SHEET 5 A 5 LYS A 45 ILE A 48 -1 O ILE A 48 N TRP A 35 SHEET 1 B 4 SER A 9 GLY A 13 0 SHEET 2 B 4 THR A 102 VAL A 106 1 O THR A 105 N VAL A 11 SHEET 3 B 4 ASP A 85 ASP A 92 -1 N TYR A 86 O THR A 102 SHEET 4 B 4 SER A 95B PHE A 98 -1 O SER A 95B N ASP A 92 SHEET 1 C 3 VAL A 19 SER A 24 0 SHEET 2 C 3 SER A 70 ILE A 75 -1 O ILE A 75 N VAL A 19 SHEET 3 C 3 PHE A 62 SER A 67 -1 N SER A 63 O ALA A 74 SHEET 1 D 4 SER A 114 PHE A 118 0 SHEET 2 D 4 ALA A 130 PHE A 139 -1 O LEU A 135 N THR A 116 SHEET 3 D 4 TYR A 172 LEU A 180 -1 O ALA A 174 N ILE A 136 SHEET 4 D 4 VAL A 159 THR A 161 -1 N GLU A 160 O TYR A 177 SHEET 1 E 4 SER A 114 PHE A 118 0 SHEET 2 E 4 ALA A 130 PHE A 139 -1 O LEU A 135 N THR A 116 SHEET 3 E 4 TYR A 172 LEU A 180 -1 O ALA A 174 N ILE A 136 SHEET 4 E 4 SER A 165 LYS A 166 -1 N SER A 165 O ALA A 173 SHEET 1 F 4 SER A 153 VAL A 155 0 SHEET 2 F 4 THR A 145 ALA A 150 -1 N ALA A 150 O SER A 153 SHEET 3 F 4 TYR A 191 HIS A 197 -1 O GLN A 194 N ALA A 147 SHEET 4 F 4 SER A 200 VAL A 206 -1 O VAL A 202 N VAL A 195 SHEET 1 G 4 GLN B 3 GLN B 6 0 SHEET 2 G 4 LEU B 18 SER B 25 -1 O ARG B 23 N VAL B 5 SHEET 3 G 4 THR B 77 TRP B 82 -1 O ALA B 78 N CYS B 22 SHEET 4 G 4 THR B 68 ASP B 72 -1 N SER B 70 O TYR B 79 SHEET 1 H 6 GLU B 10 LYS B 12 0 SHEET 2 H 6 THR B 107 VAL B 111 1 O THR B 110 N GLU B 10 SHEET 3 H 6 GLY B 88 LEU B 95 -1 N GLY B 88 O VAL B 109 SHEET 4 H 6 TRP B 33 GLN B 39 -1 N GLN B 39 O MET B 89 SHEET 5 H 6 LEU B 45 ILE B 51 -1 O GLU B 46 N ARG B 38 SHEET 6 H 6 THR B 57 TYR B 59 -1 O ASN B 58 N ARG B 50 SHEET 1 I 4 GLU B 10 LYS B 12 0 SHEET 2 I 4 THR B 107 VAL B 111 1 O THR B 110 N GLU B 10 SHEET 3 I 4 GLY B 88 LEU B 95 -1 N GLY B 88 O VAL B 109 SHEET 4 I 4 SER B 100D TRP B 103 -1 O ASN B 102 N ARG B 94 SHEET 1 J 4 SER B 120 LEU B 124 0 SHEET 2 J 4 THR B 135 TYR B 145 -1 O LYS B 143 N SER B 120 SHEET 3 J 4 TYR B 176 PRO B 185 -1 O VAL B 184 N ALA B 136 SHEET 4 J 4 VAL B 163 THR B 165 -1 N HIS B 164 O VAL B 181 SHEET 1 K 4 SER B 120 LEU B 124 0 SHEET 2 K 4 THR B 135 TYR B 145 -1 O LYS B 143 N SER B 120 SHEET 3 K 4 TYR B 176 PRO B 185 -1 O VAL B 184 N ALA B 136 SHEET 4 K 4 VAL B 169 LEU B 170 -1 N VAL B 169 O SER B 177 SHEET 1 L 3 THR B 151 TRP B 154 0 SHEET 2 L 3 ILE B 195 HIS B 200 -1 O ASN B 199 N THR B 151 SHEET 3 L 3 THR B 205 LYS B 210 -1 O THR B 205 N HIS B 200 SHEET 1 M11 CYS C 31 GLU C 34 0 SHEET 2 M11 ARG C 38 CYS C 41 -1 O THR C 40 N HIS C 32 SHEET 3 M11 THR C 56 ILE C 60 1 O LYS C 58 N VAL C 39 SHEET 4 M11 ARG C 80 SER C 84 1 O TYR C 82 N LEU C 59 SHEET 5 M11 HIS C 105 THR C 111 1 O ARG C 109 N VAL C 83 SHEET 6 M11 PHE C 130 THR C 136 1 O GLY C 132 N ILE C 108 SHEET 7 M11 PHE C 153 THR C 159 1 O GLU C 157 N ILE C 133 SHEET 8 M11 THR C 179 LYS C 183 1 O LYS C 183 N LEU C 156 SHEET 9 M11 LEU C 202 TYR C 206 1 O TYR C 206 N LEU C 182 SHEET 10 M11 LEU C 230 ASP C 232 1 O LEU C 230 N VAL C 205 SHEET 11 M11 GLU C 251 ILE C 253 1 O ILE C 253 N LEU C 231 SHEET 1 N 3 THR C 66 ILE C 67 0 SHEET 2 N 3 GLN C 91 LEU C 92 1 O GLN C 91 N ILE C 67 SHEET 3 N 3 TYR C 116 ILE C 117 1 O TYR C 116 N LEU C 92 SHEET 1 O 2 PHE C 97 TYR C 98 0 SHEET 2 O 2 LEU C 122 LYS C 123 1 O LYS C 123 N PHE C 97 SHEET 1 P 3 SER C 166 ILE C 167 0 SHEET 2 P 3 SER C 191 VAL C 192 1 O SER C 191 N ILE C 167 SHEET 3 P 3 VAL C 215 ILE C 216 1 O VAL C 215 N VAL C 192 SSBOND 1 CYS A 23 CYS A 88 1555 1555 2.04 SSBOND 2 CYS A 134 CYS A 193 1555 1555 2.03 SSBOND 3 CYS B 22 CYS B 92 1555 1555 2.04 SSBOND 4 CYS B 140 CYS B 196 1555 1555 2.04 SSBOND 5 CYS C 31 CYS C 41 1555 1555 2.03 LINK ND2 ASN A 26 C1 NAG A 213 1555 1555 1.45 LINK C1 NAG C 1 ND2 ASN C 198 1555 1555 1.45 LINK C1 NAG C 2 ND2 ASN C 177 1555 1555 1.45 LINK C1 NAG C 3 ND2 ASN C 99 1555 1555 1.45 LINK C1 NAG C 5 ND2 ASN C 113 1555 1555 1.45 LINK C1 NAG C 6 ND2 ASN C 77 1555 1555 1.45 LINK NE2 HIS A 188 ZN ZN A 304 1555 1555 1.86 LINK O HOH B 257 ZN ZN C 301 1555 1555 2.19 LINK NE2 HIS C 63 ZN ZN C 301 1555 1555 2.08 LINK OE2 GLU C 93 ZN ZN C 302 1555 1555 2.02 LINK OD2 ASP C 118 ZN ZN C 303 1555 1555 1.79 CISPEP 1 TYR A 140 PRO A 141 0 -1.00 CISPEP 2 PHE B 146 PRO B 147 0 -10.74 CISPEP 3 GLU B 148 PRO B 149 0 3.14 CISPEP 4 GLY C 227 PRO C 228 0 1.61 CRYST1 43.888 175.784 205.806 90.00 90.00 90.00 I 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022785 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005689 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004859 0.00000